Addressing the Unequal Burden of Kidney Disease on Black Americans

Published on August 18, 2023

As kidney specialists, I'm sure we all know the statistic that chronic kidney disease is a worldwide epidemic, with 1 in 7 adults in the US affected by CKD and one third of the population at risk. However, Black and African Americans are disproportionally impacted by chronic kidney disease and have higher rates of kidney failure: though comprising 13% of the US population, Black and African Americans make up 35% of people with kidney failure.

Continue reading on website
Other news

The AFFINITY Study: Seeking 20 FSGS Patients

August 15, 2023
The AFFINITY study is a global, open-label, phase 2 basket trial evaluating the safety and efficacy of atrasentan, an endothelin receptor antagonist, in patients with proteinuric glomerular diseases including IgA nephropathy, Alport syndrome, diabetic kidney disease and FSGS.

EXPLORING THE NICHE: GLOMERULAR DISEASE MANAGEMENT IN NEPHROLOGY

August 25, 2023
Navigating the complexities of glomerular diseases (GD) in nephrology is no small feat. These rare conditions demand specialized knowledge and tailored management. Let's dive into the significance of this niche and the challenges faced by those who pursue expertise in this area.